| Year |
Citation |
Score |
| 2023 |
Wang X, Jacobs D, Salmon DP, Feldman HH, Edland SD. Optimal Weighting of Preclinical Alzheimer's Cognitive Composite (PACC) Scales to Improve their Performance as Outcome Measures for Alzheimer's Disease Clinical Trials. International Journal of Statistics in Medical Research. 12: 90-96. PMID 38487620 DOI: 10.6000/1929-6029.2023.12.12 |
0.311 |
|
| 2023 |
Edland SD, Llibre-Guerra JJ. Semorinemab in Mild to Moderate Alzheimer Disease: A Glimmer of Hope Though Cautions Remain. Neurology. PMID 37643886 DOI: 10.1212/WNL.0000000000207861 |
0.326 |
|
| 2023 |
Wang X, Broce I, Qiu Y, Deters KD, Fan CC, Dale AM, Edland SD, Banks SJ. A simple genetic stratification method for lower cost, more expedient clinical trials in early Alzheimer's disease: A preliminary study of tau PET and cognitive outcomes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36701211 DOI: 10.1002/alz.12952 |
0.383 |
|
| 2022 |
Tsiknia AA, Edland SD, Sundermann EE, Reas ET, Brewer JB, Galasko D, Banks SJ. Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression. Molecular Psychiatry. PMID 35768637 DOI: 10.1038/s41380-022-01675-8 |
0.322 |
|
| 2021 |
Levey AI, Qiu D, Zhao L, Hu WT, Duong DM, Higginbotham L, Dammer EB, Seyfried NT, Wingo TS, Hales CM, Gámez Tansey M, Goldstein DS, Abrol A, Calhoun VD, Goldstein FC, ... ... Edland SD, et al. A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. Brain : a Journal of Neurology. PMID 34919634 DOI: 10.1093/brain/awab452 |
0.341 |
|
| 2021 |
Smirnov DS, Salmon DP, Galasko D, Goodwill VS, Hansen LA, Zhao Y, Edland SD, Léger GC, Peavy GM, Jacobs DM, Rissman R, Pizzo DP, Hiniker A. Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study. Neurology. PMID 34810247 DOI: 10.1212/WNL.0000000000013107 |
0.382 |
|
| 2021 |
Smirnov DS, Galasko D, Hiniker A, Edland S, Salmon DP. Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease. Neurology. PMID 33722993 DOI: 10.1212/WNL.0000000000011772 |
0.349 |
|
| 2020 |
Smirnov DS, Galasko D, Edland SD, Filoteo JV, Hansen LA, Salmon DP. Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies. Neurology. PMID 32332125 DOI: 10.1212/Wnl.0000000000009434 |
0.37 |
|
| 2019 |
Banks SJ, Shifflett B, Berg JL, Sundermann E, Peavy G, Bondi MW, Edland SD. Sex-specific composite scales for longitudinal studies of incipient Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 508-514. PMID 31650007 DOI: 10.1016/J.Trci.2019.07.003 |
0.354 |
|
| 2019 |
Thomas KR, Edmonds EC, Eppig JS, Wong CG, Weigand AJ, Bangen KJ, Jak AJ, Delano-Wood L, Galasko DR, Salmon DP, Edland SD, Bondi MW. MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31495605 DOI: 10.1016/J.Jalz.2019.06.4948 |
0.367 |
|
| 2019 |
Thomas KR, Eppig JS, Weigand AJ, Edmonds EC, Wong CG, Jak AJ, Delano-Wood L, Galasko DR, Salmon DP, Edland SD, Bondi MW. Artificially low mild cognitive impairment to normal reversion rate in Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30610833 DOI: 10.1016/J.Jalz.2018.10.008 |
0.349 |
|
| 2018 |
Smirnov DS, Galasko D, Hansen LA, Edland SD, Brewer JB, Salmon DP. Trajectories of cognitive decline differ in hippocampal sclerosis and Alzheimer's disease. Neurobiology of Aging. 75: 169-177. PMID 30579145 DOI: 10.1016/J.Neurobiolaging.2018.11.015 |
0.415 |
|
| 2018 |
Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Chételat G, Ciro C, Cohen AD, Dilworth-Anderson P, Dodge HH, ... ... Edland S, et al. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30555031 DOI: 10.1016/J.Jalz.2018.09.009 |
0.377 |
|
| 2018 |
Flanagan ME, Cholerton B, Latimer CS, Hemmy LS, Edland SD, Montine KS, White LR, Montine TJ. TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study. Journal of Alzheimer's Disease : Jad. PMID 30452409 DOI: 10.3233/Jad-180162 |
0.351 |
|
| 2018 |
Soria JA, Huisa BN, Edland SD, Litvan I, Peavy GM, Salmon DP, Hansen LA, Galasko DR, Brewer JB, González HM, Rissman RA. Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers. Journal of Alzheimer's Disease : Jad. PMID 30412501 DOI: 10.3233/Jad-180789 |
0.338 |
|
| 2018 |
Wong CG, Thomas KR, Edmonds EC, Weigand AJ, Bangen KJ, Eppig JS, Jak AJ, Devine SA, Delano-Wood L, Libon DJ, Edland SD, Au R, Bondi MW. Neuropsychological Criteria for Mild Cognitive Impairment in the Framingham Heart Study's Old-Old. Dementia and Geriatric Cognitive Disorders. 46: 253-265. PMID 30391953 DOI: 10.1159/000493541 |
0.301 |
|
| 2018 |
Wang H, Stewart T, Toledo JB, Ginghina C, Tang L, Atik A, Aro P, Shaw LM, Trojanowski JQ, Galasko DR, Edland S, Jensen PH, Shi M, Zhang J. A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. 61: 1541-1553. PMID 29376878 DOI: 10.3233/Jad-171013 |
0.431 |
|
| 2017 |
Xiao MF, Xu D, Craig MT, Pelkey KA, Chien CC, Shi Y, Zhang J, Resnick S, Pletnikova O, Salmon D, Brewer J, Edland S, Wegiel J, Tycko B, Savonenko A, et al. NPTX2 and cognitive dysfunction in Alzheimer's Disease. Elife. 6. PMID 28440221 DOI: 10.7554/Elife.23798 |
0.375 |
|
| 2017 |
Xiao M, Xu D, Craig MT, Pelkey KA, Chien C, Shi Y, Zhang J, Resnick S, Pletnikova O, Salmon D, Brewer J, Edland S, Wegiel J, Tycko B, Savonenko A, et al. Author response: NPTX2 and cognitive dysfunction in Alzheimer’s Disease Elife. DOI: 10.7554/Elife.23798.027 |
0.361 |
|
| 2016 |
Peavy GM, Edland SD, Toole BM, Hansen LA, Galasko DR, Mayo AM. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies. Parkinsonism & Related Disorders. PMID 27475955 DOI: 10.1016/J.Parkreldis.2016.07.008 |
0.366 |
|
| 2013 |
Peavy GM, Salmon DP, Edland SD, Tam S, Hansen LA, Masliah E, Galasko D, Hamilton JM. Neuropsychiatric features of frontal lobe dysfunction in autopsy-confirmed patients with lewy bodies and "pure" Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 509-19. PMID 23567425 DOI: 10.1016/J.Jagp.2012.10.022 |
0.341 |
|
| 2013 |
Sherzai A, Edland SD, Masliah E, Hansen L, Pizzo DP, Sherzai A, Corey-Bloom J. Spongiform change in dementia with Lewy bodies and Alzheimer disease. Alzheimer Disease and Associated Disorders. 27: 157-61. PMID 22546782 DOI: 10.1097/Wad.0B013E318256D507 |
0.315 |
|
| 2013 |
Rissman RA, Donohue M, Moghadam S, Sun C, Roe A, Edland S, Aisen P. Factors that influence use of plasma beta-amyloid as a biomarker of Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.08.189 |
0.334 |
|
| 2013 |
Ard MC, Galasko D, Salmon D, Edland S. P4-227: Assessing rates of cognitive decline in Alzheimer's disease and dementia with Lewy bodies Alzheimer's & Dementia. 9: P788-P788. DOI: 10.1016/J.Jalz.2013.05.1619 |
0.451 |
|
| 2013 |
Edland S. Evidence of learning or placebo effects relevant to clinical trials of mild cognitive impairment Alzheimers & Dementia. 9: 676. DOI: 10.1016/J.Jalz.2013.04.328 |
0.329 |
|
| 2012 |
Pillai J, Edland S, Gahagan T, Salmon D, Galasko D. Clinical and Neuropsychological Features of Pure and Mixed Hippocampal Sclerosis Dementia (P05.039) Neurology. 78: P05.039-P05.039. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P05.039 |
0.455 |
|
| 2010 |
McEvoy LK, Edland SD, Holland D, Hagler DJ, Roddey JC, Fennema-Notestine C, Salmon DP, Koyama AK, Aisen PS, Brewer JB, Dale AM. Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease. Alzheimer Disease and Associated Disorders. 24: 269-77. PMID 20683184 DOI: 10.1097/Wad.0B013E3181D1B814 |
0.327 |
|
| 2009 |
Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology. 72: 2115-21. PMID 19528519 DOI: 10.1212/Wnl.0B013E3181Aa52D3 |
0.313 |
|
| 2007 |
Tariot PN, Thal L, Jakimovich L, Schneider L, Cummings J, Raman R, Edland S. P-205: Valproate therapy to attenuate the clinical progression of Alzheimer's disease: Design of the ADCS valproate neuroprotection trial Alzheimer's & Dementia. 3: S163-S164. DOI: 10.1016/J.Jalz.2007.04.110 |
0.365 |
|
| 2006 |
Sano M, Zhu CW, Whitehouse PJ, Edland S, Jin S, Ernstrom K, Thomas RG, Thal LJ, Ferris SH. ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly. Alzheimer Disease and Associated Disorders. 20: S191-202. PMID 17135812 DOI: 10.1097/01.Wad.0000213875.63171.87 |
0.435 |
|
| 2006 |
Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, Sano M, Whitehouse PJ, Edland S, Thal LJ. ADCS Prevention Instrument Project: overview and initial results. Alzheimer Disease and Associated Disorders. 20: S109-23. PMID 17135805 DOI: 10.1097/01.Wad.0000213870.40300.21 |
0.424 |
|
| 2004 |
Geda YE, Smith GE, Knopman DS, Boeve BF, Tangalos EG, Ivnik RJ, Mrazek DA, Edland SD, Petersen RC. De novo genesis of neuropsychiatric symptoms in mild cognitive impairment (MCI). International Psychogeriatrics / Ipa. 16: 51-60. PMID 15190996 DOI: 10.1017/S1041610204000067 |
0.378 |
|
| 2003 |
Tang-Wai DF, Knopman DS, Geda YE, Edland SD, Smith GE, Ivnik RJ, Tangalos EG, Boeve BF, Petersen RC. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. Archives of Neurology. 60: 1777-81. PMID 14676056 DOI: 10.1001/Archneur.60.12.1777 |
0.35 |
|
| 2003 |
Kantarci K, Reynolds G, Petersen RC, Boeve BF, Knopman DS, Edland SD, Smith GE, Ivnik RJ, Tangalos EG, Jack CR. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. Ajnr. American Journal of Neuroradiology. 24: 843-9. PMID 12748083 |
0.311 |
|
| 2003 |
Knopman DS, Parisi JE, Boeve BF, Cha RH, Apaydin H, Salviati A, Edland SD, Rocca WA. Vascular dementia in a population-based autopsy study. Archives of Neurology. 60: 569-75. PMID 12707071 DOI: 10.1001/Archneur.60.4.569 |
0.321 |
|
| 2003 |
Boeve B, McCormick J, Smith G, Ferman T, Rummans T, Carpenter T, Ivnik R, Kokmen E, Tangalos E, Edland S, Knopman D, Petersen R. Mild cognitive impairment in the oldest old. Neurology. 60: 477-80. PMID 12578930 DOI: 10.1212/Wnl.60.3.477 |
0.415 |
|
| 2002 |
Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Archives of Neurology. 59: 1589-93. PMID 12374497 DOI: 10.1001/Archneur.59.10.1589 |
0.314 |
|
| 2002 |
Jack CR, Dickson DW, Parisi JE, Xu YC, Cha RH, O'Brien PC, Edland SD, Smith GE, Boeve BF, Tangalos EG, Kokmen E, Petersen RC. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology. 58: 750-7. PMID 11889239 DOI: 10.1212/Wnl.58.5.750 |
0.332 |
|
| 2000 |
Milliken JK, Edland SD. Mixed effect models of longitudinal Alzheimer's disease data: A cautionary note Statistics in Medicine. 19: 1617-1629. PMID 10844723 |
0.342 |
|
| 1998 |
Craft S, Teri L, Edland SD, Kukull WA, Schellenberg G, McCormick WC, Bowen JD, Larson EB. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology. 51: 149-53. PMID 9674794 DOI: 10.1212/Wnl.51.1.149 |
0.359 |
|
| 1997 |
Fillenbaum GG, Beekly D, Edland SD, Hughes JP, Heyman A, van Belle G. Consortium to establish a registry for Alzheimer's disease: development, database structure, and selected findings Topics in Health Information Management. 18: 47-58. PMID 10173753 |
0.337 |
|
| 1996 |
Graves AB, Larson EB, Edland SD, Bowen JD, McCormick WC, McCurry SM, Rice MM, Wenzlow A, Uomoto JM. Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project. American Journal of Epidemiology. 144: 760-71. PMID 8857825 DOI: 10.1093/Oxfordjournals.Aje.A009000 |
0.313 |
|
| 1996 |
Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, Morris JC. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, part XII Neurology. 46: 136-141. PMID 8559362 DOI: 10.1212/Wnl.46.1.136 |
0.421 |
|
| 1995 |
Davis PC, Gearing M, Gray L, Mirra SS, Morris JC, Edland SD, Lin T, Heyman A. The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease. Neurology. 45: 178-9. PMID 7824112 DOI: 10.1212/Wnl.45.1.178 |
0.308 |
|
| 1995 |
Teri L, McCurry SM, Edland SD, Kukull WA, Larson EB. Cognitive decline in Alzheimer’s disease: A longitudinal investigation of risk factors for accelerated decline Journals of Gerontology - Series a Biological Sciences and Medical Sciences. 50: M49-M55. PMID 7814789 DOI: 10.1093/Gerona/50A.1.M49 |
0.333 |
|
| 1995 |
McDaniel KD, Edland SD, Heyman A. Relationship between level of insight and severity of dementia in Alzheimer disease. CERAD Clinical Investigators. Consortium to Establish a Registry for Alzheimer's Disease. Alzheimer Disease and Associated Disorders. 9: 101-4. PMID 7662321 |
0.385 |
|
| 1995 |
Galasko D, Edland SD, Morris JC, Clark C, Mohs R, Koss E. The consortium to establish a registry for alzheimer's disease (cerad).: Part xi. clinical milestones in patients with alzheimer's disease followed over 3 years Neurology. 45: 1451-1455. PMID 7644039 DOI: 10.1212/WNL.45.8.1451 |
0.418 |
|
| 1994 |
Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 44: 609-14. PMID 8164812 DOI: 10.1212/Wnl.44.4.609 |
0.444 |
|
| 1994 |
Silverman JM, Raiford K, Edland S, Fillenbaum G, Morris JC, Clark CM, Kukull W, Heyman A. The consortium to establish a registry for Alzheimer’s disease(CERAD): Part VI. Family history assessment: A multicenter study of first-degree relatives of Alzheimer’s disease probands and nondemented spouse controls Neurology. 44: 1253-1259. PMID 8035925 DOI: 10.1212/Wnl.44.7.1253 |
0.375 |
|
| 1993 |
Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, Van Belle G, Fillenbaum G, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology. 43: 2457-2465. PMID 8255439 DOI: 10.1212/Wnl.43.12.2457 |
0.465 |
|
| Show low-probability matches. |